A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine
NCT04825678
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
240
Enrollment
INDUSTRY
Sponsor class
Conditions
Migraine
Interventions
DRUG:
Erenumab
Sponsor
Amgen